Removing the FDA’s Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.19873
Abstract: Key Points Question How did use of and liver function tests (LFTs) for ambrisentan vs bosentan change after the boxed hepatotoxicity warning and LFT requirement under the risk evaluation and mitigation strategy (REMS) were removed… read more here.
Keywords: liver function; boxed hepatotoxicity; hepatotoxicity warning; ambrisentan bosentan ... See more keywords